Pfizer (PFE) Announces FDA Acceptance for Priority Review of sBLA for 20vPnC
Go back to Pfizer (PFE) Announces FDA Acceptance for Priority Review of sBLA for 20vPnC| Pfizer Inc. (NYSE: PFE) | Delayed: 27.53 -0.11 (0.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.64 | 52 Week High | $37.39 | |||
| Open | $27.64 | 52 Week Low | $28.25 | |||
| Day High | $27.66 | P/E | 16.68 | |||
| Day Low | $27.34 | EPS | $1.65 | |||
| Volume | 14,454,334 | |||||

